BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 26304888)

  • 1. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.
    Feijen EA; Leisenring WM; Stratton KL; Ness KK; van der Pal HJ; Caron HN; Armstrong GT; Green DM; Hudson MM; Oeffinger KC; Robison LL; Stovall M; Kremer LC; Chow EJ
    J Clin Oncol; 2015 Nov; 33(32):3774-80. PubMed ID: 26304888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity.
    Feijen EAM; Leisenring WM; Stratton KL; Ness KK; van der Pal HJH; van Dalen EC; Armstrong GT; Aune GJ; Green DM; Hudson MM; Loonen J; Oeffinger KC; Robison LL; Yasui Y; Kremer LCM; Chow EJ
    JAMA Oncol; 2019 Jun; 5(6):864-871. PubMed ID: 30703192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
    Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
    Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study.
    van der Pal HJ; van Dijk IW; Geskus RB; Kok WE; Koolen M; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC; van Dalen EC
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):213-22. PubMed ID: 25442333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
    Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
    Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic surveillance for asymptomatic late-onset anthracycline cardiomyopathy in childhood cancer survivors.
    Abosoudah I; Greenberg ML; Ness KK; Benson L; Nathan PC
    Pediatr Blood Cancer; 2011 Sep; 57(3):467-72. PubMed ID: 21280201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional Study.
    Mulrooney DA; Armstrong GT; Huang S; Ness KK; Ehrhardt MJ; Joshi VM; Plana JC; Soliman EZ; Green DM; Srivastava D; Santucci A; Krasin MJ; Robison LL; Hudson MM
    Ann Intern Med; 2016 Jan; 164(2):93-101. PubMed ID: 26747086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.
    Sorensen K; Levitt G; Bull C; Chessells J; Sullivan I
    J Clin Oncol; 1997 Jan; 15(1):61-8. PubMed ID: 8996125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac safety of liposomal anthracyclines.
    Ewer MS; Martin FJ; Henderson C; Shapiro CL; Benjamin RS; Gabizon AA
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):161-81. PubMed ID: 15717742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
    Skubitz KM; Blaes AH; Konety SH; Francis GS
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study.
    Chow AY; Chin C; Dahl G; Rosenthal DN
    J Clin Oncol; 2006 Feb; 24(6):925-8. PubMed ID: 16484703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?
    van den Berg MP; van Spaendonck-Zwarts KY; van Veldhuisen DJ; Gietema JA; Postma A; van Tintelen JP
    Eur J Heart Fail; 2010 Dec; 12(12):1297-9. PubMed ID: 20952769
    [No Abstract]   [Full Text] [Related]  

  • 14. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.
    Hudson MM; Rai SN; Nunez C; Merchant TE; Marina NM; Zalamea N; Cox C; Phipps S; Pompeu R; Rosenthal D
    J Clin Oncol; 2007 Aug; 25(24):3635-43. PubMed ID: 17704413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy-associated cardiomyopathy in survivors of childhood cancer.
    Hines MR; Mulrooney DA; Hudson MM; Ness KK; Green DM; Howard SC; Krasin M; Metzger ML
    J Cancer Surviv; 2016 Feb; 10(1):113-21. PubMed ID: 26044903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late echocardiography assessment of systolic and diastolic function of the left ventricle in pediatric cancer survivors after anthracycline therapy.
    Santin JC; Deheinzelin D; Junior SP; Lopes LF; de Camargo B
    J Pediatr Hematol Oncol; 2007 Nov; 29(11):761-5. PubMed ID: 17984694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukaemia.
    Gulen H; Kazanci E; Mese T; Uzunkaya D; Erbay A; Tavli V; Vergin C
    Minerva Pediatr; 2007 Apr; 59(2):107-13. PubMed ID: 17404560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed cardiac toxicity from anthracycline therapy.
    Steinherz L; Steinherz P
    Pediatrician; 1991; 18(1):49-52. PubMed ID: 1983861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines.
    van Dalen EC; van der Pal HJ; van den Bos C; Kok WE; Caron HN; Kremer LC
    Eur J Cancer; 2006 Oct; 42(15):2549-53. PubMed ID: 16919450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer: Results From the St. Jude Lifetime Cohort Study.
    Armstrong GT; Joshi VM; Ness KK; Marwick TH; Zhang N; Srivastava D; Griffin BP; Grimm RA; Thomas J; Phelan D; Collier P; Krull KR; Mulrooney DA; Green DM; Hudson MM; Robison LL; Plana JC
    J Am Coll Cardiol; 2015 Jun; 65(23):2511-22. PubMed ID: 26065990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.